⚡
RLHF & Preference Data at Clinical Grade
We run preference ranking sessions with physicians, nurses, and pharmacists on your model's outputs. They compare response pairs, rank by clinical accuracy, flag harmful content, and generate the reward signal your training pipeline needs — delivered as JSONL or CSV.
Preference Pairs
DPO / PPO Data
Reward Modeling
RLHF
🔬
SFT Dataset Creation & Medical Annotation
Domain experts write high-quality clinical instruction-response pairs, annotate medical records and literature, validate AI-generated content, and build the labeled datasets your supervised fine-tuning runs demand. From clinical notes to drug monographs.
SFT Examples
Clinical Annotation
Synthetic Data QA
NER & Labeling
🔐
Red-Teaming & AI Safety Testing
Clinicians run structured adversarial probing on your model — generating edge-case prompts, testing drug-drug interactions, checking diagnostic reasoning errors, and identifying demographic bias patterns. You get a red-team report and a curated failure dataset.
Adversarial Prompting
Hallucination Detection
Bias Auditing
Safety Reports
📊
Model Evaluation & Clinical Benchmarking
We deploy specialist panels to score your model on custom eval rubrics — clinical correctness, safety, empathy, reasoning quality, and regulatory alignment. Results feed directly into your model card, pre-deployment checklist, or FDA/CE submission evidence.
Expert Scoring
Clinical Benchmarks
Eval Pipelines
Model Cards
🧬
Patient & Caregiver Panels for Model Robustness
Real patients across 10 disease areas interact with your AI product and expose the edge cases your synthetic test sets miss — rare symptom combinations, health literacy gaps, medication confusion, emotional distress responses. Delivered as structured usability and interaction logs.
Real-World Edge Cases
UX Failure Logs
Disease-Specific Panels
Interaction Data
🛡️
Clinical Trial & Post-Market Research Support
For AI companies whose products are entering regulatory pathways or supporting clinical research — we provide investigator identification, patient pre-screening across 10 disease panels, pharmacovigilance cohort recruitment, and Phase IV real-world evidence generation.
Site Feasibility
Patient Pre-Screening
Phase IV Recruitment
RWE & HEOR